PAK4 and cancer: While there is limited reports showing PAK3 expression in cancers, PAK1 over-expression has been linked to ovarian, breast, bladder and lymph cancers, while elevated PAK2, PAK4 and PAK6 expression has also been observed in prostate cancer [22].